The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Transforming AAV capsid analysis with single particle analysis using mass photometry
Article
At Thermo Fisher Scientific, we are committed to investing in breakthrough technologies like mass photometry (MP), a cutting-edge innovation that is revolutionizing gene therapy with rapid, precise, and cost-effective AAV capsid analysis. Traditional methods like analytical ultracentrifugation (AUC) are time-consuming, costly, and often fall short in addressing the high-throughput demands of modern gene therapy development. MP offers single-particle resolution to accurately characterize empty, partially full, and full AAV capsids, ensuring the purity and efficacy of gene therapy vectors. Learn how mass photometry works, key advantages and see accuracy and precision results from a pilot study.
Download the article to learn more about mass photometry.
